Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
08/2002
08/08/2002WO2002020762A3 Tnf receptor-like molecules and uses thereof
08/08/2002WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
08/08/2002WO2002000885A3 Assembly of wild-type and chimeric influenza virus-like particles (vlps)
08/08/2002WO2002000840A3 Human lyases
08/08/2002WO2001096546A3 Protein phosphatases
08/08/2002WO2001096393A3 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
08/08/2002WO2001092547A3 Modified bovine adenovirus having altered tropism
08/08/2002WO2001090330A3 AMINOACYL tRNA SYNTHETASES
08/08/2002WO2001085926A3 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
08/08/2002WO2001085664A3 Compounds and methods for regulating bacterial growth and pathogenesis
08/08/2002WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec)
08/08/2002WO2001079421A3 Apparatus and methods for testing effects of materials and surface coatings on the formation of biofilms
08/08/2002WO2001051641A9 Irak-4: compositions and methods of use
08/08/2002WO2001034802A9 Compositions and methods for the therapy and diagnosis of prostate cancer
08/08/2002WO2001023604A3 Highly conserved genes and their use to generate probes and primers for detection of microorganisms
08/08/2002WO2001021799A9 Traf4 associated cell cycle proteins, compositions and methods of use
08/08/2002US20020108148 Nucleic acid sequences to proteins involved in isoprenoid synthesis
08/08/2002US20020108146 Expression vector for use in the generation of disease resistant plants
08/08/2002US20020107385 Human breast tumor-specific proteins
08/08/2002US20020107380 Nucleotide sequences coding polypeptide fpr use in the human therapeutics, pharmacology, foods and animal feeds
08/08/2002US20020107378 Nucleotide sequences coding preferential operon for use in the genration of threonine for use in humans therapeutics, foods and animal nutrients
08/08/2002US20020107377 Nucleotide sequences coding polypeptide for use in the generation of lysine for use in human medicines, foods and animal nutrients
08/08/2002US20020107376 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of liver disorders and cancer
08/08/2002US20020107374 Coding sequence for protein phosphatase methylesterase, recombinant DNA molecules and methods
08/08/2002US20020107370 Protein for use in the treatment of lzheimer's, parkinson's, amyotrophic lateral sclerosis, multiple sclerosis, retinopathy, brain, blood, myocardium, stroke, reperfusion injury and liver disorders
08/08/2002US20020107368 Helicobacter proteins, gene sequences and uses thereof
08/08/2002US20020107364 Compositions and methods for regulating bacterial pathogenesis
08/08/2002US20020107363 B7-Like molecules and uses thereof
08/08/2002US20020107362 Novel fluorescent proteins
08/08/2002US20020107361 Novel metalloproteases having thrombospondin domains and nucleic acid compositions encoding the same
08/08/2002US20020107180 Cell surface glycoproteins
08/08/2002US20020106789 A Polynucleotide
08/08/2002US20020106780 Extracellular matrix polynucleotides, polypeptides, and antibodies
08/08/2002US20020106778 Human PTTG polypeptide and method for producing it
08/08/2002US20020106776 pth
08/08/2002US20020106770 25233, a novel human aminotransferase and uses therefor
08/08/2002US20020106769 UDP-D-glucose: limonoid glucosyltransferase
08/08/2002US20020106768 Pesticidal protein for use in biological pest controlth Cry6A toxin
08/08/2002US20020106760 Nucleotide sequences which code for the dps gene
08/08/2002US20020106757 Polynucleotide sequences which code enzymatic polypeptide for use generation of preferential amino acid for use in human medicine, foods and animal nutrients
08/08/2002US20020106755 Nucleotide sequences coding for the sigM gene
08/08/2002US20020106753 L-amino acid oxidase from Rhodococcus species
08/08/2002US20020106751 Nucleotide sequences coding for the pstC2 gene
08/08/2002US20020106749 Polynucleotide sequences coding enzymatic polypeptide for use in fermentaion of amino acids for use in human medicine, foods and animal nutrients
08/08/2002US20020106748 Polynucleotide which code enzymatic polypetide for use in genration of lysine
08/08/2002US20020106743 IL-17 homologous polypeptides and therapeutic uses thereof
08/08/2002US20020106742 Nucleic acids encoding active and inactive CCR5 chemokine receptors
08/08/2002US20020106732 Smad6 and uses thereof
08/08/2002US20020106731 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of apoptosis and inflammation defects
08/08/2002US20020106729 Nucleotide sequences for use as tools in genetic engineering
08/08/2002US20020106728 NS4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
08/08/2002US20020106726 Peptide for use in the treatment of inflammation defects
08/08/2002US20020106725 Generating preferential enzymatic polypeptide for use in foods, animal feed, pharmacology, and dentistry
08/08/2002US20020106724 RNA-binding protein
08/08/2002US20020106723 Receptor for latrotoxin from insects
08/08/2002US20020106694 Use of computer to designing preferential polypeptides; obtain computer, input polypeptide sequence data, adjust polypeptide sequence data, analyse potential activities associated with adjustment
08/08/2002US20020106680 Joining preferential nucleotide sequences; generate solid phase, incubate with nucleotide sequences, remove nucleotide sequence which have protrusions from terminals, recover bound nucleotide sequences
08/08/2002US20020106671 Identification of a capacitative calcium channel in antigen presenting cells and uses thereof
08/08/2002US20020106655 Nucleotide sequences coding preferential protein for use in the treatment, diagnosis and prevention of immunological, nervous system and tumor disorders
08/08/2002US20020106650 Nucleotide sequence coding preferential polypeptide; for use in the treatment, prevention and diagnosis of kidney, liver, reproductive and cardiovascular disorders
08/08/2002US20020106642 Protease for use in the treatment and prevention of viral disease and infections
08/08/2002US20020106639 Postweaning multisystemic wasting syndrome virus from pigs
08/08/2002US20020106631 Recombinant, active caspases and uses thereof
08/08/2002US20020106629 Genetically engineering preferential immunoglobulins in cells; obtain cells, transform with vector containing genetically engineered immunoglobulin, recover transformed cells, propagate, recover immunoglobulin
08/08/2002US20020106378 Materials and methods for intracellular transport and their uses
08/08/2002US20020106333 Enamel matrix related polypeptide
08/08/2002DE10104952A1 Vektorsystem zum Screening von Wirkstoffen Vector system for screening active substances
08/08/2002CA2437342A1 Method for producing recombinant trypsin
08/08/2002CA2437121A1 Juvenile hormone esterase
08/08/2002CA2437021A1 Adiponectin-associated protein
08/08/2002CA2436770A1 Methods of treating inflammatory and immune diseases using inhibitors of ikb kinase (ikk)
08/08/2002CA2436661A1 Novel nucleic acid and polypeptide molecules
08/08/2002CA2436530A1 Environmentally regulated genes of streptococcus suis
08/08/2002CA2436281A1 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
08/08/2002CA2434968A1 Method for the evolutionary design of biochemical reaction networks
08/08/2002CA2434953A1 Protein modification and maintenance molecules
08/08/2002CA2434822A1 Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof
08/08/2002CA2434626A1 Microorganisms and processes for enhanced production of pantothenate
08/08/2002CA2432973A1 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
08/08/2002CA2432867A1 A novel human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1
08/08/2002CA2432731A1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences
08/08/2002CA2430886A1 Compositions and methods for rapidly generating recombinant nucleic acid molecules
08/08/2002CA2428248A1 Solubility reporter gene constructs
08/08/2002CA2426856A1 Thuja plicata dirigent protein promoters
08/07/2002EP1229126A1 Process for producing carotenoid pigments
08/07/2002EP1229122A2 Chimeric isoprenoid synthases and uses thereof
08/07/2002EP1229121A2 Method for producing L-glutamine by fermentation and L-glutamine producing bacterium
08/07/2002EP1229117A2 Crystals of the human TRAIL/sDR5 (TNF-related apoptosis-inducing ligand/extracellular domain of DR5 receptor) complex, their three-dimensional structure and uses thereof
08/07/2002EP1229114A1 Gene encoding protein capable of regenerating luciferin, novel recombinant dna and process for producing protein capable of regenerating luciferin
08/07/2002EP1229113A2 Recombinational cloning using engineered recombination sites
08/07/2002EP1229045A1 Universal carrier for targeting molecules to Gb3 receptor expressing cells
08/07/2002EP1228769A1 Symbiotic regenerative composition
08/07/2002EP1228233A2 Methods and compositions comprising renilla gfp
08/07/2002EP1228224A1 Recombinant attenuated listerias for immunotherapy
08/07/2002EP1228222A2 Human transferase molecules
08/07/2002EP1228221A2 Human sphingosine kinase gene
08/07/2002EP1228218A2 5r clavam producing microorganisms with deleted lat and cvm genes
08/07/2002EP1228214A2 Erythropoietin forms with improved properties
08/07/2002EP1228206A2 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions
08/07/2002EP1228203A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof